Evidence map›Paper›PMID 41263569›Full record

ArticleMicrobiology spectrum2026

Impact of carbapenem-resistant

Wenwen Ding, Zongxin Ling, Xia Liu, Jingchen Zhang, Yiwen Cheng, Zhangcheng Zhu, Lingbin Wu, Xiaocui Xu, Yongtao Gao, Xiaogang Hu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Wenwen Ding *Department of Anesthesiology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Jiangsu, China.
Zongxin Ling *State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, China-Singapore Belt and Road Joint Laboratory on Infection Research and Drug Development, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID 0000-0001-9662-099X
Xia Liu *Department of Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jingchen Zhang *Department of Intensive Care Unit, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yiwen ChengState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, China-Singapore Belt and Road Joint Laboratory on Infection Research and Drug Development, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Zhangcheng ZhuDepartment of Preventive Medicine, School of Public Health and Management, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lingbin WuDepartment of Laboratory Medicine, Lishui Second People's Hospital, Lishui, Zhejiang, China.
Xiaocui XuDepartment of Anesthesiology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Jiangsu, China.
Yongtao GaoDepartment of Anesthesiology, Affiliated Hospital of Nantong University, Medical School of Nantong University, Jiangsu, China.ORCID 0009-0008-1792-8493
Xiaogang HuDepartment of Intensive Care Unit, Lishui Second People's Hospital, Lishui, Zhejiang, China.ORCID 0009-0000-4923-0702

Funding

Foundation of SKLID ZZ202316 and ZZ202319Fundamental Research Funds for the Central Universities 2025ZFJH03Jiangsu Provincial Research Hospital YJXYY202204-YSB31National Science and Technology Major Project 2023YFC2308400Shandong Provincial Laboratory Project SYS202202Taishan Scholar Project of Shandong Province tsqn202103119
6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Carbapenem-Resistant EnterobacteriaceaeCarbapenemsGastrointestinal MicrobiomeKlebsiella InfectionsKlebsiella pneumoniaeAdultAgedAnti-Bacterial AgentsCase-Control StudiesCytokinesFecesFemaleHumansMaleMiddle AgedProspective StudiesAnti-Bacterial AgentsCarbapenemsCytokinesRNA, Ribosomal, 16Senterotypegut microbiotainflammationKlebsiella pneumoniaemultiplex immunoassayssequencing

Identifiers

PMID41263569
PMCPMC12772321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.